Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Non Small Cell Lung Cancer
Drug:
carboplatin
(
Tubulin polymerization promoter
) +
pemetrexed
(
Thymidylate synthase inhibitor
,
THF dehydrogenase inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Non-Small Cell Lung Cancer: Useful in Certain Circumstances...Carboplatin/pemetrexed…
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.